Press Releases from DelveInsight Business Research LLP (2397 total)
Pyoderma Gangrenosum Market to Show Incremental Growth During the Forecast Perio …
DelveInsight's "Pyoderma Gangrenosum Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Pyoderma Gangrenosum, historical and forecasted epidemiology as well as the Pyoderma Gangrenosum market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Pyoderma Gangrenosum market report provides current treatment practices, emerging drugs, Pyoderma Gangrenosum market share of the individual therapies, and current and forecasted Pyoderma Gangrenosum market…
CNS Lymphoma Market to Show a Rise During the Forecast Period | Major players: S …
DelveInsight's "CNS Lymphoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the CNS Lymphoma, historical and forecasted epidemiology as well as the CNS Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The CNS Lymphoma market report provides current treatment practices, emerging drugs, CNS Lymphoma market share of the individual therapies, and current and forecasted CNS Lymphoma market…
Beta-thalassemia (B-thal) Pipeline Analysis Covering Clinical Trials, Emerging T …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 22+ key pharma and biotech companies are working on 22+ pipeline drugs in the Beta Thalassemia therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Beta-thalassemia (B-thal) Pipeline Insight" report by…
Community-Acquired Bacterial Pneumonia Market to Show a Rise During the Forecast …
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current…
DDR Defective Tumors Market to Show a Rise During the Forecast Period, asserts D …
DelveInsight's "DDR Defective Tumors Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the DDR Defective Tumors, historical and forecasted epidemiology as well as the DDR Defective Tumors market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The DDR Defective Tumors market report provides current treatment practices, emerging drugs, DDR Defective Tumors market share of the individual therapies, and current…
Invasive Pneumococcal Disease Market to Show a Rise During the Forecast Period | …
DelveInsight's "Invasive Pneumococcal Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Invasive Pneumococcal Disease, historical and forecasted epidemiology as well as the Invasive Pneumococcal Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Invasive Pneumococcal Disease market report provides current treatment practices, emerging drugs, Invasive Pneumococcal Disease market share of the individual therapies, and current…
Pancreatic Cancer Pipeline Analysis Covering Clinical Trials, Emerging Therapies …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 290+ key pharma and biotech companies are working on 300+ pipeline drugs in the Pancreatic Cancer therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Pancreatic Cancer Pipeline Insight" report by…
Primary Myelofibrosis Market to Show a Rise During the Forecast Period | Major c …
DelveInsight's "Primary Myelofibrosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Primary Myelofibrosis, historical and forecasted epidemiology as well as the Primary Myelofibrosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Primary Myelofibrosis market report provides current treatment practices, emerging drugs, Primary Myelofibrosis market share of the individual therapies, and current and forecasted Primary Myelofibrosis market…
Non-Hodgkin's Lymphoma (NHL) Pipeline Analysis Covering Clinical Trials, Emergin …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 200+ key pharma and biotech companies are working on 220+ pipeline drugs in the Non-Hodgkin's Lymphoma therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Non-Hodgkin's Lymphoma (NHL) Pipeline Insight" report…
Malignant Melanoma Pipeline Analysis Covering Clinical Trials, Emerging Therapie …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, several major pharma and biotech companies are working on various pipeline therapies in the Malignant Melanoma therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Malignant Melanoma Pipeline Insight" report by DelveInsight…
Glioma Pipeline, FDA Approvals, Clinical Trials Developments and Companies | Ast …
DelveInsight's, "Glioma Pipeline Insight" report provides comprehensive insights about 190+ companies and 130+ pipeline drugs in the Glioma pipeline landscape. It covers the Glioma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Glioma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Glioma Pipeline Report
• DelveInsight's Glioma pipeline…
Colorectal Cancer Pipeline, FDA Approvals, Clinical Trials Development and Compa …
DelveInsight's, "Colorectal Cancer Pipeline Insight" report provides comprehensive insights about 145+ companies and 150+ pipeline drugs in the Colorectal Cancer pipeline landscape. It covers the Colorectal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Colorectal Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Colorectal…
Eczema Pipeline, FDA Approvals, Clinical Trials Developments and Companies | LEO …
DelveInsight's, "Eczema Pipeline Insight" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Eczema pipeline landscape. It covers the Eczema pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Eczema pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Eczema Pipeline Report
• DelveInsight's Eczema pipeline report…
B-Cell Lymphomas Pipeline, FDA Approvals, Clinical Trials Developments and Compa …
DelveInsight's, "B-Cell Lymphoma Pipeline Insight" report provides comprehensive insights about 160+ companies and 170+ pipeline drugs in B-Cell Lymphoma pipeline landscape. It covers the B-Cell Lymphomas pipeline drug profiles, including clinical and nonclinical stage products. It also covers the B-Cell Lymphomas pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the B-Cell Lymphomas…
Alzheimer's Disease Pipeline, FDA Approvals, Clinical Trials Developments, and C …
DelveInsight's, "Alzheimer's Disease Pipeline Insights" report provides comprehensive insights about 150+ companies and 160+ pipeline drugs in Alzheimer's Disease pipeline landscape. It covers the Alzheimer's Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Alzheimer's Disease pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Alzheimer's Disease…
Amyotrophic Lateral Sclerosis Pipeline, FDA Approvals, Clinical Trials Developme …
DelveInsight's, "Amyotrophic Lateral Sclerosis Pipeline Insight" report provides comprehensive insights about 90+ companies and 100+ pipeline drugs in Amyotrophic Lateral Sclerosis pipeline landscape. It covers the Amyotrophic Lateral Sclerosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Amyotrophic Lateral Sclerosis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways…
Advanced Hepatocellular Carcinoma Pipeline, FDA Approvals, Clinical Trials Devel …
DelveInsight's, "Advanced Hepatocellular Carcinoma Pipeline Insight" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Advanced Hepatocellular Carcinoma pipeline landscape. It covers the Advanced Hepatocellular Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Advanced Hepatocellular Carcinoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways…
Brain Metastases Pipeline, FDA Approvals, Clinical Trial Development and Compani …
DelveInsight's, "Brain Metastases Pipeline Insight" report provides comprehensive insights about 40+ Brain Metastases companies and 45+ pipeline drugs in Brain Metastases pipeline landscape. It covers the Brain Metastases pipeline drug profiles, including clinical and nonclinical stage products. Brain Metastases pipeline report also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the…
Cholangiocarcinoma Pipeline, FDA Approvals, Clinical Trials Developments and Com …
DelveInsight's, "Cholangiocarcinoma Pipeline Insight" report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Cholangiocarcinoma pipeline landscape. It covers the Cholangiocarcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Cholangiocarcinoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Cholangiocarcinoma Pipeline Report
• DelveInsight's Cholangiocarcinoma pipeline report…
Septic Shock Pipeline Analysis Covering Clinical Trials, Emerging Therapies, FDA …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in the Septic Shock therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Septic Shock Pipeline Insight, 2023" report…
Atopic Dermatitis Pipeline Analysis Covering Clinical Trials, Emerging Therapies …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 100+ key pharma and biotech companies are working on 100+ pipeline drugs in the Atopic Dermatitis therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Atopic Dermatitis Pipeline Insight, 2023" report…
Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) Pipeline Analysis Coveri …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, several major pharma and biotech companies are actively working on various pipeline drugs in the Gastroenteropancreatic Neuroendocrine Tumors therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) Pipeline…
Bladder Cancer Pipeline Analysis Covering Clinical Trials, Emerging Therapies, F …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 80+ key pharma and biotech companies are working on 100+ pipeline drugs in the Bladder Cancer therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Bladder Cancer Pipeline Insight, 2023" report…
Peripheral Nerve Injuries Pipeline Analysis Covering Clinical Trials, Emerging T …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in the Peripheral Nerve Injuries therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Peripheral Nerve Injuries Pipeline Insight,…
Renal Anemia Market to Show Incremental Growth During the Forecast Period | Majo …
DelveInsight's "Renal Anemia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Renal Anemia, historical and forecasted epidemiology as well as the Renal Anemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Renal Anemia market report provides current treatment practices, emerging drugs, Renal Anemia market share of the individual therapies, current and forecasted Renal Anemia market Size…
Tinnitus Market to Show Incremental Growth During the Forecast Period | Major co …
DelveInsight's "Tinnitus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Tinnitus, historical and forecasted epidemiology as well as the Tinnitus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Tinnitus market report provides current treatment practices, emerging drugs, Tinnitus market share of the individual therapies, current and forecasted Tinnitus market Size from 2019 to 2032 segmented by…
Myocarditis Market to Show Incremental Growth During the Forecast Period | Major …
DelveInsight's "Myocarditis Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Myocarditis, historical and forecasted epidemiology as well as the Myocarditis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Myocarditis market report provides current treatment practices, emerging drugs, Myocarditis market share of the individual therapies, current and forecasted Myocarditis market Size from 2017 to 2030 segmented by seven…
Erythromelalgia Market to Show Incremental Growth During the Forecast Period | M …
DelveInsight's "Erythromelalgia- Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Erythromelalgia, historical and forecasted epidemiology as well as the Erythromelalgia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Erythromelalgia market report provides current treatment practices, emerging drugs, Erythromelalgia market share of the individual therapies, current and forecasted Erythromelalgia market Size from 2019 to 2032 segmented by…
Lassa Fever Market to Show Incremental Growth During the Forecast Period | Major …
DelveInsight's "LassaFever- Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Lassa Fever, historical and forecasted epidemiology as well as the Lassa Fever market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Lassa Fever market report provides current treatment practices, emerging drugs, Lassa Fever market share of the individual therapies, current and forecasted Lassa Fever market Size from…
Gallbladder Cancer Market to Show Incremental Growth During the Forecast Period …
DelveInsight's "Gallbladder Cancer Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Gallbladder Cancer, historical and forecasted epidemiology as well as the Gallbladder Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Gallbladder Cancer market report provides current treatment practices, emerging drugs, Gallbladder Cancer market share of the individual therapies, current and forecasted Gallbladder Cancer market Size from…
LAG-3-Next Generation Immunotherapy Market to Showcase Robust Growth in the Upco …
DelveInsight's "Lymphocyte Activation Gene-3 (LAG-3) Competitive Landscape and Market Forecast - 2035" report delivers an in-depth understanding of the LAG-3, historical and forecasted market trends of LAG-3 in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The report covers a descriptive overview including history, mechanism, principles, categories, advantages/ limitations of LAG-3 Next-generation Immunotherapies, and currently available therapies from 2019 to 2035 segmented by seven major markets.…
Diffuse Large B-Cell Lymphoma Pipeline, FDA Approvals, Clinical Trials Developme …
DelveInsight's, "Diffuse Large B-Cell Lymphoma Pipeline Insight" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Diffuse Large B-Cell Lymphoma pipeline landscape. It covers the Diffuse Large B-cell lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diffuse Large B-cell lymphoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in…
Transdermal Drug Delivery Devices Market to Witness a Robust Growth in the Upcom …
The global transdermal drug delivery devices market is growing at a CAGR of 9.8% during the forecast period from 2023 to 2028. The demand for transdermal drug delivery devices is primarily witnessing growth on account of the increasing prevalence of chronic conditions, increase in adoption of third-generation transdermal drug delivery devices, technological advancements observed in the device, and the use of these devices from hormonal disorders to cardiovascular conditions and…
Esophageal Squamous Cell Carcinoma Pipeline, FDA Approvals, Clinical Trials Deve …
DelveInsight's, "Esophageal Squamous Cell Carcinoma Pipeline Insight" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Esophageal Squamous Cell Carcinoma pipeline landscape. It covers the Esophageal Squamous Cell Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways…
Metastatic Renal Cell Carcinoma Pipeline, FDA Approvals, Clinical Trials Develop …
DelveInsight's, "Metastatic Renal Cell Carcinoma Pipeline Insight" report provides comprehensive insights about 40+ companies and 50+ pipeline drugs in Metastatic Renal Cell Carcinoma pipeline landscape. It covers the Metastatic Renal Cell Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Metastatic Renal Cell Carcinoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in…
Mesothelioma Pipeline, FDA Approvals, Clinical Trials Development and Companies …
DelveInsight's, "Mesothelioma Pipeline Insight" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Mesothelioma pipeline landscape. It covers the Mesothelioma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Mesothelioma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Mesothelioma Pipeline Report
• DelveInsight's Mesothelioma pipeline…
Marginal Zone Lymphoma Pipeline, FDA Approvals, Clinical Trials Development and …
DelveInsight's, "Marginal Zone Lymphoma Pipeline Insight" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Marginal Zone Lymphoma pipeline landscape. It covers the Marginal Zone Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Marginal Zone Lymphoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways…
HR Positive/ HER2 Negative Breast Cancer Pipeline, Clinical Trials Developments …
DelveInsight's, "HR Positive/ HER2 Negative Breast Cancer Pipeline Insights" report provides comprehensive insights about 50+ companies and 53+ pipeline drugs in HR Positive/ HER2 Negative Breast Cancer pipeline landscape. It covers the HR Positive/ HER2 Negative Breast Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the HR Positive/ HER2 Negative Breast Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type.…
EGFR Non-Small Cell Lung Cancer Pipeline, FDA Approvals, Clinical Trials Develop …
DelveInsight's, "EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) Pipeline Insights" report provides comprehensive insights about 40+ EGFR Non-Small Cell Lung Cancer companies and 42+ pipeline drugs in the EGFR Non-Small Cell Lung Cancer pipeline landscape. It covers the EGFR Non-Small Cell Lung Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the EGFR Non-Small Cell Lung Cancer pipeline therapeutics assessment by product type, stage, route…
Follicular Lymphoma Pipeline, FDA Approvals, Clinical Trials Developments and Co …
DelveInsight's, "Follicular Lymphoma Pipeline Insight" report provides comprehensive insights about 50+ Follicular Lymphoma companies and 50+ pipeline drugs in the Follicular Lymphoma pipeline landscape. It covers the Follicular Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Follicular Lymphoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from…
Urothelial Carcinoma Pipeline, FDA Approvals, Clinical Trials Assessment and Com …
DelveInsight's, "Urothelial Carcinoma Pipeline Insight" report provides comprehensive insights about 40+ Urothelial Carcinoma companies and 50+ pipeline drugs in the Urothelial Carcinoma pipeline landscape. It covers the Urothelial Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Urothelial Carcinoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from…
Recurrent Glioblastoma Pipeline, FDA Approvals, Clinical Trials Assessment and C …
DelveInsight's, "Recurrent Glioblastoma Pipeline Insight" report provides comprehensive insights about 50+ Recurrent Glioblastoma companies and 50+ pipeline drugs in Recurrent Glioblastoma pipeline landscape. It covers the Recurrent Glioblastoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Recurrent Glioblastoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the…
Artificial Pancreas Device System Market: Insights into Competitive Landscape an …
DelveInsight's 'Artificial Pancreas Device System - Market Insight, Competitive Landscape and Market Forecast, 2026' report delivers an in-depth understanding of Artificial Pancreas Device System and the historical and forecasted Artificial Pancreas Device System market trends, globally, which comprises of North America, Europe, APAC, and Rest of the World.
Request for a sample copy of the Artificial Pancreas Device System Market report @ https://www.delveinsight.com/sample-request/artificial-pancreas-device-system-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
The Artificial Pancreas Device System market report offers an…
Orthotic Devices Market to Showcase Robust Growth in the Upcoming Years | Major …
Global Orthotic Devices Market was valued at USD 2.51 billion in 2021, growing at a CAGR of 5.13% during the forecast period from 2023 to 2028 to reach USD 3.38 billion by 2028. Factors such as the growing prevalence of degenerative bone disorders, rising prevalence of neuromuscular diseases, increasing geriatric population, rising number of accident and trauma cases, and the rising number of sports-related injuries among other factors are expected…
Medical Sterilization Equipment Market Trends | Major players: GETINGE AB, STERI …
Global Medical Sterilization Equipment Market was valued at USD 5.43 billion in 2020, growing at a CAGR of 6.04% during the forecast period from 2023 to 2028, to reach USD 7.68 billion by 2028. The demand for Medical Sterilization Equipment is primarily motivated by the outbreak of the COVID-19 pandemic, rising burden of chronic diseases, rising number of surgical procedures, and increasing investment in healthcare.
The Medical Sterilization Equipment market report…
Colonoscopes Pipeline Insights into Key Pharma Players, Pipeline Devices, Growth …
DelveInsight's "Colonoscopes - Pipeline Insight and Competitive Landscape, 2023," report provides comprehensive insights about 20+ companies and 20+ pipeline devices in Colonoscopes pipeline landscape.
A colonoscope is a thin, tube-like instrument with visible light and a lens. It may also have a tool for removing tissue for signs of illness to be checked under a microscope. Fewer people will die from colorectal cancer if healthcare professionals accept a new screening…
Vaso-Occlusive Crisis Market to Show Incremental Growth During the Forecast Peri …
DelveInsight's "Vaso-Occlusive Crisis Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Vaso-Occlusive Crisis Market Size and Share in the 7MM (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).
The Vaso-Occlusive Crisis market report covers emerging drugs, treatment practices, market share of the individual therapies, and current & forecasted market size…
Dry Eye Disease Market to Show Incremental Growth During the Study Period | Majo …
DelveInsight's "Dry Eye Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Dry Eye Disease, historical and forecasted epidemiology as well as the Dry Eye Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Dry Eye Disease market report provides current treatment practices, emerging drugs, Dry Eye Disease market share of the individual therapies, current and forecasted…
Cutaneous Squamous Cell Carcinoma Pipeline Analysis Covering Clinical Trials, Em …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 45+ key pharma and biotech companies are working on 45+ pipeline drugs in the Cutaneous Squamous Cell Carcinoma therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Cutaneous Squamous Cell Carcinoma…
Cystic Fibrosis Pipeline Analysis Covering Clinical Trials, Emerging Therapies, …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 75+ key pharma and biotech companies are working on 80+ pipeline drugs in the Cystic Fibrosis therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Cystic Fibrosis Pipeline Insight" report by…
